Tag: Metabolic Diseases

Survodutide Reduces Liver Fat and Weight in Obesity and At-Risk MASLD

June 8, 2026

Survodutide Reduces Liver Fat and Weight in Obesity and At-Risk MASLD

Dapagliflozin and Heart Failure Risk in Carriers of Rare Cardiomyopathy Variants

June 8, 2026

Dapagliflozin and Heart Failure Risk in Carriers of Rare Cardiomyopathy Variants

EMBRAZE Phase 2 Trial: Apitegromab and Tirzepatide for Lean Body Mass Preservation

June 8, 2026

EMBRAZE Phase 2 Trial: Apitegromab and Tirzepatide for Lean Body Mass Preservation

Trifluridine/Tipiracil Fails to Improve Disease-Free Survival in ctDNA-Positive Colorectal Cancer

June 8, 2026

Trifluridine/Tipiracil Fails to Improve Disease-Free Survival in ctDNA-Positive Colorectal Cancer

Lung Cancer Risk Factors, Vaping Impacts, and Screening Guidelines

June 8, 2026

Lung Cancer Risk Factors, Vaping Impacts, and Screening Guidelines

Oral Aleniglipron Leads to 11.3% Weight Loss in Phase 2b Obesity Trial

June 6, 2026

Oral Aleniglipron Leads to 11.3% Weight Loss in Phase 2b Obesity Trial

Targeting Inflammation: A New Frontier in Cardiovascular Disease Treatment

June 5, 2026

Targeting Inflammation: A New Frontier in Cardiovascular Disease Treatment

Evaluating the Effectiveness of AI in Influenza Vaccine Strain Selection

June 5, 2026

Evaluating the Effectiveness of AI in Influenza Vaccine Strain Selection

Improving Emotion Regulation in LGBTQ+ Youth Using Purrble: A Randomized Controlled Trial

June 4, 2026

Improving Emotion Regulation in LGBTQ+ Youth Using Purrble: A Randomized Controlled Trial

Advances in Familial Hypercholesterolemia Treatment and Gene Therapy

June 4, 2026

Advances in Familial Hypercholesterolemia Treatment and Gene Therapy

Web Analytics